Evidence map›Paper›PMID 37891476›Full record

ArticleBMC infectious diseases2023

Antibiotic use and consumption among medical patients of two hospitals in Sierra Leone: a descriptive report.

Sulaiman Lakoh, Christine Ellen Elleanor Williams, Stephen Sevalie, James B W Russell, Sarah K Conteh, Joseph Sam Kanu, Umu Barrie, Gibrilla F Deen, Anna Maruta, Daniel Sesay and 5 more

Abstract read
In one paragraph

Article in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Sulaiman LakohCollege of Medicine and Allied Health Sciences, University of Sierra Leone, New England, Freetown, Sierra Leone. lakoh2009@gmial.com.
Christine Ellen Elleanor WilliamsCollege of Medicine and Allied Health Sciences, University of Sierra Leone, New England, Freetown, Sierra Leone.
Stephen SevalieCollege of Medicine and Allied Health Sciences, University of Sierra Leone, New England, Freetown, Sierra Leone.
James B W RussellCollege of Medicine and Allied Health Sciences, University of Sierra Leone, New England, Freetown, Sierra Leone.
Sarah K ContehMinistry of Health and Sanitation, Government of Sierra Leone, Freetown, Sierra Leone.
Joseph Sam KanuCollege of Medicine and Allied Health Sciences, University of Sierra Leone, New England, Freetown, Sierra Leone.
Umu BarrieInfectious Disease Research Network, Freetown, Sierra Leone.
Gibrilla F DeenCollege of Medicine and Allied Health Sciences, University of Sierra Leone, New England, Freetown, Sierra Leone.
Anna MarutaWorld Health Organization Country Office, Freetown, Sierra Leone.
Daniel SesayMinistry of Health and Sanitation, Government of Sierra Leone, Freetown, Sierra Leone.
Olukemi AdekanmbiDepartment of Medicine, College of Medicine, University of Ibadan, Ibadan, Nigeria.
Darlinda F JibaMinistry of Health and Sanitation, Government of Sierra Leone, Freetown, Sierra Leone.
Joseph Chukwudi OkeibunorWorld Health Organization Regional Office for Africa, Brazzaville, Congo.
George A YendewaDepartment of Medicine, Case Western Reserve University School of Medicine, Ohio, USA.
Emmanuel FirimaDepartment of Medicine, Clinical Research Unit, Swiss Tropical and Public Health Institute, Basel, Switzerland.

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundAlthough one of the main drivers of antimicrobial resistance is inappropriate antibiotic prescribing, there are limited resources to support the surveillance of antibiotic consumption in low-income countries. In this study, we aimed to assess antibiotic use and consumption among medical patients of two hospitals in different geographic regions of Sierra Leone.

methodsThis is a cross-sectional study of adult (18 years or older) patients receiving medical care at two hospitals (34 Military Hospital-MH and Makeni Government Hospital-MGH) between March 2021 and October 2021. After admission to the medical or intensive care unit, patients were sequentially recruited by a nurse from each hospital. Demographic and clinical characteristics and information on the dose of antibiotics, their routes, and frequency of administration and duration were collected using a questionnaire adapted from previous studies and encrypted in EpiCollect software (Epic, Verona WI). A physician reviews and verifies each completed questionnaire. Data analysis was done using STATA version 16.

resultsThe mean age of the 468 patients evaluated in this study was 48.6 years. The majority were women (241, 51.7%) and treated at MGH (245, 52.0%). Clinical diagnosis of bacterial infection was made in only 180 (38.5%) patients. Regardless of the diagnosis, most (442, 94.9%) patients received at least one antibiotic. Of a total 813 doses of antibiotics prescribed by the two hospitals, 424 (52.2%) were administered in MH. Overall, antibiotic consumption was 66.9 defined daily doses (DDDs) per 100 bed-days, with ceftriaxone being the most commonly used antibiotic (277, 34.1%). The ACCESS and WATCH antibiotics accounted for 18.9 DDDs per 100 bed-days (28.2%) and 48.0 DDDs per 100 bed-days (71.7%), respectively. None of the patients were prescribed a RESERVE antibiotics. The antibiotic consumption was lower in MH (61.3 DDDs per 100 bed-days) than MGH (76.5 DDDs per 100 bed-days).

conclusionAntibiotic consumption was highest with ceftriaxone, followed by levofloxacin and metronidazole. Given the high rate of consumption of antibiotics in the WATCH category of the AWaRe classification, there is a need to initiate surveillance of antibiotic consumption and establish hospital-based antibiotic stewardship in these settings.

Indexed as

Anti-Bacterial AgentsCeftriaxoneAdultCross-Sectional StudiesDrug UtilizationFemaleHospitals, PublicHumansMaleMiddle AgedSierra LeoneAnti-Bacterial AgentsCeftriaxoneACCESS, WATCH and RESERVE (AWaRe)Antibiotic consumptionAntimicrobial resistance (AMR)Defined daily dose (DDD)Sierra Leone

Identifiers

PMID37891476
PMCPMC10612171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.